Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

Rousselot, Philippe, Charbonnier, Aude, Cony-Makhoul, Pascale · Journal of Clinical Oncology · 2014